Biologics Market: By Source, By Product, By Disease, By Drug Classification, By Distribution Channel and Geography.

download arrow download arrow Download Free Sample
settings arrow settings arrow email us

Biologics Market Size, Share, Growth, Trends, and Global Industry Analysis: By Source (Microbial, Mammalia Others), By Product (MABs, Vaccine, Hormones, Therapeutic Enzymes, Recombinant Proteins, Antisense, RNAi & Molecular Therapy, Blood Factors and Anticoagulants, Allergenic extracts, Human Cells and Tissues, Proteins, Gene Therapies, Cellular Therapies Others), By Disease (Oncology, Immunological Disorders, Cardiovascular Disorders, Hematological Disorders Others), By Drug Classification (Branded Drugs, Generic Drugs), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and Region.

checked icon arrow_drop_down
checked icon Single User License $4400
checked icon Multiple User License $6600
checked icon Corporate User License $8900

1. Executive Summary
2. Global Biologics Market Introduction
2.1. Global Biologics Market – Taxonomy
2.2. Global Biologics Market –Definitions
2.2.1. By Source
2.2.2. By Product
2.2.3. By Disease
2.2.4. By Drug Classification
2.2.5. By Distribution Channel
2.2.6. By Region
3. Global Biologics Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Biologics Market Dynamic Factors - Impact Analysis
3.6. Global Biologics Market – Competition Landscape
4. Global Biologics Market Analysis, 2018-2022 and Forecast, 2023-2029
4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, US$ Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis
5. Global Biologics Market, By Source, 2018-2022 and Forecast, 2023-2029 (Revenue, US$ Mn)
5.1. Microbial
5.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, US$ Mn)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Mammalian
5.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, US$ Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
5.3. Others
5.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, US$ Mn)
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3. Market Opportunity Analysis
6. Global Biologics Market, By Product, 2018-2022 and Forecast, 2023-2029 (Revenue, US$ Mn)
6.1. MABs
6.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, US$ Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Vaccines
6.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, US$ Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. Hormones
6.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, US$ Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
6.4. Therapeutic Enzymes
6.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, US$ Mn)
6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.4.3. Market Opportunity Analysis
6.5. Recombinant Proteins
6.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, US$ Mn)
6.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.5.3. Market Opportunity Analysis
6.6. Antisense, RNAi & Molecular Therapy
6.6.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, US$ Mn)
6.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.6.3. Market Opportunity Analysis
6.7. Blood Factors and Anticoagulants
6.7.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, US$ Mn)
6.7.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.7.3. Market Opportunity Analysis
6.8. Allergenic extracts
6.8.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, US$ Mn)
6.8.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.8.3. Market Opportunity Analysis
6.9. Human Cells and Tissues
6.9.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, US$ Mn)
6.9.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.9.3. Market Opportunity Analysis
6.10. Proteins
6.10.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, US$ Mn)
6.10.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.10.3. Market Opportunity Analysis
6.11. Gene Therapies
6.11.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, US$ Mn)
6.11.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.11.3. Market Opportunity Analysis
6.12. Cellular Therapies
6.12.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, US$ Mn)
6.12.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.12.3. Market Opportunity Analysis
6.13. Others
6.13.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, US$ Mn)
6.13.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.13.3. Market Opportunity Analysis
7. Global Biologics Market, By Disease, 2018-2022 and Forecast, 2023-2029 (Revenue, US$ Mn)
7.1. Oncology
7.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, US$ Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Immunological Disorders
7.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, US$ Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Cardiovascular Disorders
7.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, US$ Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
7.4. Hematological Disorders
7.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, US$ Mn)
7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.4.3. Market Opportunity Analysis
7.5. Others
7.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, US$ Mn)
7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.5.3. Market Opportunity Analysis
8. Global Biologics Market Forecast, By Drug Classification, 2018-2022 and Forecast, 2023-2029 (Revenue, US$ Mn)
8.1. Branded Drugs
8.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, US$ Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.1.3. Market Opportunity Analysis
8.2. Generic Drugs
8.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, US$ Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.2.3. Market Opportunity Analysis
9.  Global Biologics Market Forecast, By Distribution Channel, 2018-2022 and Forecast, 2023-2029 (Revenue, US$ Mn)
9.1. Hospital Pharmacies
9.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, US$ Mn)
9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.1.3. Market Opportunity Analysis
9.2. Retail Pharmacies
9.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, US$ Mn)
9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.2.3. Market Opportunity Analysis
9.3. Online Pharmacies
9.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, US$ Mn)
9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.3.3. Market Opportunity Analysis
10.  Global Biologics Market Forecast, By Region, 2018-2022 and Forecast, 2023-2029 (Revenue, US$ Mn)
10.1. North America
10.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, US$ Mn)
10.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
10.1.3. Market Opportunity Analysis
10.2. Europe
10.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, US$ Mn)
10.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
10.2.3. Market Opportunity Analysis
10.3. Asia-Pacific
10.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, US$ Mn)
10.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
10.3.3. Market Opportunity Analysis
10.4. Latin America
10.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, US$ Mn)
10.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
10.4.3. Market Opportunity Analysis
10.5. Middle East and Africa
10.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, US$ Mn)
10.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
10.5.3. Market Opportunity Analysis
10.6. Global Biologics Market - Opportunity Analysis Index, By Source, By Product, By Disease, By Drug Classification, By Distribution Channel, and Region, 2023-2029
11. North America Biologics Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, US$ Mn)
11.1. Source Analysis 2018-2022 and Forecast 2023-2029 by Revenue (US$ Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.1. Microbial
11.1.2. Mammalian
11.1.3. Others
11.2. Product Analysis 2018-2022 and Forecast 2023-2029 by Revenue (US$ Mn), Y-o-Y Growth (%), and Market Share (%)
11.2.1. MABs
11.2.2. Vaccines
11.2.3. Hormones
11.2.4. Therapeutic Enzymes
11.2.5. Recombinant Proteins
11.2.6. Antisense, RNAi & Molecular Therapy
11.2.7. Blood Factors and Anticoagulants
11.2.8. Allergenic extracts
11.2.9. Human Cells and Tissues
11.2.10. Proteins
11.2.11. Gene Therapies
11.2.12. Cellular Therapies
11.2.13. Others
11.3. Disease Analysis 2018-2022 and Forecast 2023-2029 by Revenue (US$ Mn), Y-o-Y Growth (%) and Market Share (%)
11.3.1. Oncology
11.3.2. Immunological Disorders
11.3.3. Cardiovascular Disorders
11.3.4. Hematological Disorders
11.3.5. Others
11.4. Drug Classification Analysis 2018-2022 and Forecast 2023-2029 by Revenue (US$ Mn), Y-o-Y Growth (%) and Market Share (%)
11.4.1. Branded Drugs
11.4.2. Generic Drugs
11.5. Distribution Channel Analysis 2018-2022 and Forecast 2023-2029 by Revenue (US$ Mn), Y-o-Y Growth (%) and Market Share (%)
11.5.1. Hospital Pharmacies
11.5.2. Retail Pharmacies
11.5.3. Online Pharmacies
11.6. Country Analysis 2018-2022 and Forecast 2023-2029 by Revenue (US$ Mn) Y-o-Y Growth (%) and Market Share (%)
11.6.1. USA
11.6.2. Canada
11.7. North America Biologics Market - Opportunity Analysis Index, By Source, By Product, By Disease, By Drug Classification, By Distribution Channel, and Country, 2023-2029
11.8. North America Biologics Market Dynamics – Trends
12. Europe Biologics Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, US$ Mn)
12.1. Source Analysis 2018-2022 and Forecast 2023-2029 by Revenue (US$ Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.1. Microbial
12.1.2. Mammalian
12.1.3. Others
12.2. Product Analysis 2018-2022 and Forecast 2023-2029 by Revenue (US$ Mn), Y-o-Y Growth (%), and Market Share (%)
12.2.1. MABs
12.2.2. Vaccines
12.2.3. Hormones
12.2.4. Therapeutic Enzymes
12.2.5. Recombinant Proteins
12.2.6. Antisense, RNAi & Molecular Therapy
12.2.7. Blood Factors and Anticoagulants
12.2.8. Allergenic extracts
12.2.9. Human Cells and Tissues
12.2.10. Proteins
12.2.11. Gene Therapies
12.2.12. Cellular Therapies
12.2.13. Others
12.3. Disease Analysis 2018-2022 and Forecast 2023-2029 by Revenue (US$ Mn), Y-o-Y Growth (%) and Market Share (%)
12.3.1. Oncology
12.3.2. Immunological Disorders
12.3.3. Cardiovascular Disorders
12.3.4. Hematological Disorders
12.3.5. Others
12.4. Drug Classification Analysis 2018-2022 and Forecast 2023-2029 by Revenue (US$ Mn), Y-o-Y Growth (%) and Market Share (%)
12.4.1. Branded Drugs
12.4.2. Generic Drugs
12.5. Distribution Channel Analysis 2018-2022 and Forecast 2023-2029 by Revenue (US$ Mn), Y-o-Y Growth (%) and Market Share (%)
12.5.1. Hospital Pharmacies
12.5.2. Retail Pharmacies
12.5.3. Online Pharmacies
12.6. Country Analysis 2018-2022 and Forecast 2023-2029 by Revenue (US$ Mn) Y-o-Y Growth (%) and Market Share (%)
12.6.1. Germany
12.6.2. UK
12.6.3. France
12.6.4. Spain
12.6.5. Italy
12.6.6. Russia
12.6.7. Rest of Europe
12.7. Europe Biologics Market - Opportunity Analysis Index, By Source, By Product, By Disease, By Drug Classification, By Distribution Channel, and Country, 2023-2029
12.8. Europe Biologics Market Dynamics – Trends
13. Asia-Pacific Biologics Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, US$ Mn)
13.1. Source Analysis 2018-2022 and Forecast 2023-2029 by Revenue (US$ Mn), Y-o-Y Growth (%), and Market Share (%)
13.1.1. Microbial
13.1.2. Mammalian
13.1.3. Others
13.2. Product Analysis 2018-2022 and Forecast 2023-2029 by Revenue (US$ Mn), Y-o-Y Growth (%), and Market Share (%)
13.2.1. MABs
13.2.2. Vaccines
13.2.3. Hormones
13.2.4. Therapeutic Enzymes
13.2.5. Recombinant Proteins
13.2.6. Antisense, RNAi & Molecular Therapy
13.2.7. Blood Factors and Anticoagulants
13.2.8. Allergenic extracts
13.2.9. Human Cells and Tissues
13.2.10. Proteins
13.2.11. Gene Therapies
13.2.12. Cellular Therapies
13.2.13. Others
13.3. Disease Analysis 2018-2022 and Forecast 2023-2029 by Revenue (US$ Mn), Y-o-Y Growth (%) and Market Share (%)
13.3.1. Oncology
13.3.2. Immunological Disorders
13.3.3. Cardiovascular Disorders
13.3.4. Hematological Disorders
13.3.5. Others
13.4. Drug Classification Analysis 2018-2022 and Forecast 2023-2029 by Revenue (US$ Mn), Y-o-Y Growth (%) and Market Share (%)
13.4.1. Branded Drugs
13.4.2. Generic Drugs
13.5. Distribution Channel Analysis 2018-2022 and Forecast 2023-2029 by Revenue (US$ Mn), Y-o-Y Growth (%) and Market Share (%)
13.5.1. Hospital Pharmacies
13.5.2. Retail Pharmacies
13.5.3. Online Pharmacies
13.6. Country Analysis 2018-2022 and Forecast 2023-2029 by Revenue (US$ Mn) Y-o-Y Growth (%) and Market Share (%)
13.6.1. China
13.6.2. India
13.6.3. Japan
13.6.4. ASEAN
13.6.5. Australia & New Zealand
13.6.6. Rest of Asia-Pacific
13.7. Asia-Pacific Biologics Market - Opportunity Analysis Index, By Source, By Product, By Disease, By Drug Classification, By Distribution Channel, and Country, 2023-2029
13.8. Asia-Pacific Biologics Market Dynamics – Trends
14. Latin America Biologics Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, US$ Mn)
14.1. Source Analysis 2018-2022 and Forecast 2023-2029 by Revenue (US$ Mn), Y-o-Y Growth (%), and Market Share (%)
14.1.1. Microbial
14.1.2. Mammalian
14.1.3. Others
14.2. Product Analysis 2018-2022 and Forecast 2023-2029 by Revenue (US$ Mn), Y-o-Y Growth (%), and Market Share (%)
14.2.1. MABs
14.2.2. Vaccines
14.2.3. Hormones
14.2.4. Therapeutic Enzymes
14.2.5. Recombinant Proteins
14.2.6. Antisense, RNAi & Molecular Therapy
14.2.7. Blood Factors and Anticoagulants
14.2.8. Allergenic extracts
14.2.9. Human Cells and Tissues
14.2.10. Proteins
14.2.11. Gene Therapies
14.2.12. Cellular Therapies
14.2.13. Others
14.3. Disease Analysis 2018-2022 and Forecast 2023-2029 by Revenue (US$ Mn), Y-o-Y Growth (%) and Market Share (%)
14.3.1. Oncology
14.3.2. Immunological Disorders
14.3.3. Cardiovascular Disorders
14.3.4. Hematological Disorders
14.3.5. Others
14.4. Drug Classification Analysis 2018-2022 and Forecast 2023-2029 by Revenue (US$ Mn), Y-o-Y Growth (%) and Market Share (%)
14.4.1. Branded Drugs
14.4.2. Generic Drugs
14.5. Distribution Channel Analysis 2018-2022 and Forecast 2023-2029 by Revenue (US$ Mn), Y-o-Y Growth (%) and Market Share (%)
14.5.1. Hospital Pharmacies
14.5.2. Retail Pharmacies
14.5.3. Online Pharmacies
14.6. Country Analysis 2018-2022 and Forecast 2023-2029 by Revenue (US$ Mn) Y-o-Y Growth (%) and Market Share (%)
14.6.1. Brazil
14.6.2. Mexico
14.6.3. Rest of Latin America
14.7. Latin America Biologics Market - Opportunity Analysis Index, By Source, By Product, By Disease, By Drug Classification, By Distribution Channel, and Country, 2023-2029
14.8. Latin America Biologics Market Dynamics – Trends
15. Middle East and Africa Biologics Market Analysis, 2018-2022 and Forecast, 2023-2029 (Revenue, US$ Mn)
15.1. Source Analysis 2018-2022 and Forecast 2023-2029 by Revenue (US$ Mn), Y-o-Y Growth (%), and Market Share (%)
15.1.1. Microbial
15.1.2. Mammalian
15.1.3. Others
15.2. Product Analysis 2018-2022 and Forecast 2023-2029 by Revenue (US$ Mn), Y-o-Y Growth (%), and Market Share (%)
15.2.1. MABs
15.2.2. Vaccines
15.2.3. Hormones
15.2.4. Therapeutic Enzymes
15.2.5. Recombinant Proteins
15.2.6. Antisense, RNAi & Molecular Therapy
15.2.7. Blood Factors and Anticoagulants
15.2.8. Allergenic extracts
15.2.9. Human Cells and Tissues
15.2.10. Proteins
15.2.11. Gene Therapies
15.2.12. Cellular Therapies
15.2.13. Others
15.3. Disease Analysis 2018-2022 and Forecast 2023-2029 by Revenue (US$ Mn), Y-o-Y Growth (%) and Market Share (%)
15.3.1. Oncology
15.3.2. Immunological Disorders
15.3.3. Cardiovascular Disorders
15.3.4. Hematological Disorders
15.3.5. Others
15.4. Drug Classification Analysis 2018-2022 and Forecast 2023-2029 by Revenue (US$ Mn), Y-o-Y Growth (%) and Market Share (%)
15.4.1. Branded Drugs
15.4.2. Generic Drugs
15.5. Distribution Channel Analysis 2018-2022 and Forecast 2023-2029 by Revenue (US$ Mn), Y-o-Y Growth (%) and Market Share (%)
15.5.1. Hospital Pharmacies
15.5.2. Retail Pharmacies
15.5.3. Online Pharmacies
15.6. Country Analysis 2018-2022 and Forecast 2023-2029 by Revenue (US$ Mn) Y-o-Y Growth (%) and Market Share (%)
15.6.1. Gulf Cooperation Council (GCC) Countries
15.6.2. South Africa
15.6.3. Rest of MEA
15.7. MEA Biologics Market - Opportunity Analysis Index By Source, By Product, By Disease, By Drug Classification, By Distribution Channel, and Country, 2023-2029
15.8. MEA Biologics Market Dynamics – Trends
16. Competition Landscape 
16.1. Strategic Dashboard of Top Market Players
16.2. Company Profiles (Introduction, Financial Analysis, Key Sources, Key Developments, Strategies, and SWOT Analysis)
16.2.1. AbbVie Inc.
16.2.2. Amgen Inc.
16.2.3. AstraZeneca plc
16.2.4. F. Hoffmann-La Roche Ltd
16.2.5. GlaxoSmithKline plc
16.2.6. Johnson & Johnson
16.2.7. Merck KGaA
16.2.8. Novartis AG
16.2.9. Pfizer Inc.
16.2.10. Sanofi
17. Research Methodology
18. Key Assumptions and Acronyms

Key Features of the Report

  • The report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
  • The report analyses the impact of the socio-political environment through PESTLE Analysis and competition through Porter's Five Force Analysis in addition to recent technology advancements and innovations in the market

Download Free Sample Report

I accept the Terms and Conditions,Disclaimers, GDPR Policy

Frequently Asked Questions

The biologics market key players are: AbbVie Inc., Amgen Inc., AstraZeneca plc, GlaxoSmithKline plc, Johnson & Johnson, Merck KGaA, Novartis AG, Pfizer Inc., Sanofi, Hoffmann-La Roche Ltd

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.

Author image

Author

Prem Kumar

Prem Kumar with profound experience and sound knowledge across a wide range of market forecasting methods, demand f.....

Key Market Players

  • AbbVie Inc.
  • Amgen Inc.
  • AstraZeneca plc
  • GlaxoSmithKline plc
  • Johnson & Johnson
  • Merck KGaA
  • Novartis AG
  • Pfizer Inc.
  • Sanofi
  • Hoffmann-La Roche Ltd

Related Industry Reports

Inkjet Printing Market

Industrial Plastics Market

Industrial Minerals Market

Industrial Absorbents Market